Seelos Therapeutics Inc (SEELQ)
0.2901
-0.20
(-41.39%)
USD |
OTCM |
Nov 22, 13:25
Seelos Therapeutics Total Assets (Quarterly): 2.381M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.381M |
| March 31, 2024 | 3.612M |
| December 31, 2023 | 5.418M |
| September 30, 2023 | 6.218M |
| June 30, 2023 | 11.89M |
| March 31, 2023 | 23.64M |
| December 31, 2022 | 22.75M |
| September 30, 2022 | 40.51M |
| June 30, 2022 | 52.67M |
| March 31, 2022 | 70.69M |
| December 31, 2021 | 83.50M |
| September 30, 2021 | 80.95M |
| June 30, 2021 | 90.31M |
| March 31, 2021 | 41.37M |
| December 31, 2020 | 17.49M |
| September 30, 2020 | 9.878M |
| June 30, 2020 | 7.76M |
| March 31, 2020 | 14.17M |
| December 31, 2019 | 11.10M |
| September 30, 2019 | 16.21M |
| June 30, 2019 | 10.28M |
| March 31, 2019 | 12.34M |
| December 31, 2018 | 3.76M |
| September 30, 2018 | 5.564M |
| June 30, 2018 | 7.222M |
| Date | Value |
|---|---|
| March 31, 2018 | 6.02M |
| December 31, 2017 | 6.706M |
| September 30, 2017 | 8.823M |
| June 30, 2017 | 8.815M |
| March 31, 2017 | 5.353M |
| December 31, 2016 | 4.70M |
| September 30, 2016 | 8.41M |
| June 30, 2016 | 6.166M |
| March 31, 2016 | 10.43M |
| December 31, 2015 | 7.781M |
| September 30, 2015 | 9.60M |
| June 30, 2015 | 11.39M |
| March 31, 2015 | 19.64M |
| December 31, 2014 | 14.81M |
| September 30, 2014 | 19.80M |
| June 30, 2014 | 20.28M |
| March 31, 2014 | 24.99M |
| December 31, 2013 | 23.31M |
| September 30, 2013 | 22.30M |
| June 30, 2013 | 26.92M |
| March 31, 2013 | 16.63M |
| December 31, 2012 | 23.88M |
| September 30, 2012 | 40.75M |
| June 30, 2012 | 29.20M |
| March 31, 2012 | 31.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.381M
Minimum
Jun 2024
90.31M
Maximum
Jun 2021
31.38M
Average
17.49M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Cassava Sciences Inc | 223.75M |
| Cara Therapeutics Inc | 51.33M |
| Citius Pharmaceuticals Inc | 97.09M |
| Moleculin Biotech Inc | 23.39M |
| 180 Life Sciences Corp | 10.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.51M |
| Shareholders Equity (Quarterly) | -28.13M |